Systematic data regarding long-term neurobehavioral effects of maternal antidepressant use during pregnancy are sparse. The aim of this study was to evaluate the impact of gestational exposure to antidepressants on later neurodevelopmental function.
Methods
This study describes a cohort of mother-child dyads (44 mothers, 54 children) in which maternal depressive symptoms and medication exposures were prospectively collected across pregnancy and the postpartum period. Children age 6 to 17 were assessed using validated instruments across domains of childhood behavior and executive memory and functioning.
Results
No associations were found between maternal use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy and atypical neurodevelopment of children. Borderline clinical or clinical ranges of internalizing symptoms were associated with exposure to a higher maternal depressive symptom burden during pregnancy compared with those in the normal range. Compared with age- and sex-matched controls, the SSRI-exposed group showed superior performance on executive function tasks; findings did not demonstrate elevated risk for abnormal neuro-development in children age 6 to 17 exposed to SSRIs in utero. Deviations from the norm were instead associated with higher in utero exposure to maternal depression burden.
Conclusions
This study highlights the need for rigorous studies of long-term outcomes after fetal antidepressant exposure.
Get full access to this article
View all access options for this article.
References
1.
SiuAL; US Preventive Services Task Force (USPSTF), Bibbins-DomingoK, . Screening for depression in adults: US Preventive Services Task Force recommendation statement. JAMA. 2016; 315: 380–387.
2.
ACOG Committee Opinion Number 757: Screening for perinatal depression. Obstet Gynecol. 2018; 132: e208–e212.
3.
EarlsMF; The Committee on Psychosocial Aspects of Child and Family Health. Incorporating recognition and management of perinatal and postpartum depression into pediatric practice. Pediatrics. 2010; 126: 1032–1039.
4.
AndradeSERaebelMABrownJ. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol. 2008; 198: 194 e191–e195.
5.
CohenLSAltshulerLLHarlowBL. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006; 295: 499–507.
6.
HuybrechtsK FPalmstenKMogunH. National trends in antidepressant medication treatment among publicly insured pregnant women. Gen Hosp Psychiatry. 2013; 35: 265–271.
7.
WemakorACassonKDolkH.Prevalence and sociodemographic patterns of antidepressant use among women of reproductive age: a prescription database study. J Affect Disord. 2014; 167: 299–305.
8.
DawsonALAilesECGilboaSM. Antidepress-ant prescription claims among reproductive-aged women - United States 2008-2013. MMWR Morb Mortal Wkly Rep. 2016; 65: 41–46.
9.
DawJRMintzesBLawMR. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006). Clin Ther. 2012; 34: 239–249.
10.
PrenoveauJMCraskeMGWestV. Maternal postnatal depression and anxiety and their association with child emotional negativity and behavior problems at two years. Dev Psychol. 2017; 53: 50–62.
11.
ShenHMagnussonCRaiD. Associations of parental depression with child school performance at age 16 years in Sweden. JAMA Psychiatry. 2016; 73: 239–246.
12.
WeissmanMMWickramaratnePNomuraY. Offspring of depressed parents: 20 years later. Am J Psychiatry. 2006; 163: 1001–1008.
13.
GoodmanSHRouseMHConnellAM. Maternal depression and child psychopathology: a meta-analytic review. Clin Child Fam Psychol Rev. 2011; 14: 1–27.
14.
AmesJLLadd-AcostaCFallinMD. Maternal psychiatric conditions, treatments with selective serotonin reuptake inhibitors, and neurodevelopmental disorders. Biol Psychiatry. 2021; 90: 253–262.
15.
BoukhrisTSheehyOMottronL. Antidepressant use during pregnancy and the risk of autism spectrum disorder in children. JAMA Pediatr. 2016; 170: 117–124.
16.
MoralesDRSlatteryJEvansS. Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations. BMC Med. 2018; 16: 6.
17.
ClementsCCCastroVMBlumenthalSR. Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system. Mol Psychiatry. 2015; 20: 727–734.
18.
SuriRLinASCohenLS. Acute and long-term behavioral outcome of infants and children exposed in utero to either maternal depression or antidepressants: a review of the literature. J Clin Psychiatry. 2014; 75: e1142–e1152.
19.
Moses-KolkoELBogenDPerelJ. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA. 2005; 293: 2372–2383.
20.
DemetriouEALampitAQuintanaDS. Autism spectrum disorders: a meta-analysis of executive function. Mol Psychiatry. 2018; 23: 1198–1204.
21.
RhodesSMParkJSethS. A comprehensive investigation of memory impairment in attention deficit hyperactivity disorder and oppositional defiant disorder. Child Psychol Psychiatry. 2012; 53: 128–137.
22.
RhodesSMCoghillDRMatthewsK.Neuropsychological functioning in stimulant-naive boys with hyperkinetic disorder. Psychol Med. 2005; 35: 1109–1120.
23.
RockPLRoiserJ PRiedelWJ. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014; 44: 2029–2040.
WisnerKLSitDKHanusaBH. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry. 2009; 166: 557–566.
26.
GroteNKBridgeJAGavinAR. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry. 2010; 67: 1012–1024.
27.
NulmanIRovetJStewartDE. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med. 1997; 336: 258–262.
28.
NulmanIRovetJStewartDE. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry. 2002; 159: 1889–1895.
29.
SuriRHellemannGStoweZN. A prospective, naturalistic, blinded study of early neurobe-havioral outcomes for infants following prenatal antidepressant exposure. J Clin Psychiatry. 2011; 72: 1002–1007.
30.
SuriRStoweZNCohenLS. Prospective longitudinal study of predictors of postpartum-onset depression in women with a history of major depressive disorder. J Clin Psychiatry. 2017; 78: 1110–1116.
31.
HarrisPATaylorRThielkeR. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009; 42: 377–381.
32.
FreemanM PClaypooleLD. Course of major depressive disorder after pregnancy and the postpartum period. Depress Anxiety. 2018; 35: 1130–1136.
33.
GuffantiGGameroffMJWarnerV. Heritability of major depressive and comorbid anxiety disorders in multi-generational families at high risk for depression. Am J Med Genet B Neuropsychiatr Genet. 2016; 171: 1072–1079.
34.
KendlerKSPrescottCA. A population-based twin study of lifetime major depression in men and women. Arch Gen Psychiatry. 1999; 56: 39–44.
35.
FanousAGardnerCOPrescottCA. Neuroticism, major depression and gender: a population-based twin study. Psychol Med. 2002; 32: 719–728.
36.
TronickEReckC.Infants of depressed mothers. Harv Rev Psychiatry. 2009; 17: 147–156.
37.
BayerJKSansonAVHemphillSA. Parent influences on early childhood internalizing difficulties. J Appl Dev Psychol. 2006; 27: 542–559.
38.
PilowskyDJWickramaratnePNomuraY. Family discord, parental depression, and psychopathology in offspring: 20-year follow-up. J Am Acad Child Adolesc Psychiatry. 2006; 45: 452–460.
39.
DrurySSScaramellaLZeanahCH. The neurobiological impact of postpartum maternal depression: prevention and intervention approaches. Child Adolesc Psychiatr Clin N Am. 2016; 25: 179–200.
40.
VerbeekTBocktingCLvan PampusMG, . Postpartum depression predicts offspring mental health problems in adolescence independently of parental lifetime psychopathology. J Affect Disord. 2012; 136: 948–954.
41.
SangerCIlesJEAndrewCS. Associations between postnatal maternal depression and psychological outcomes in adolescent offspring: a systematic review. Arch Womens Ment Health. 2015; 18: 147–162.
42.
SurkanPPatelSARahmanA.Preventing infant and child morbidity and mortality due to maternal depression. Best Pract Res Clin Obstet Gynaecol. 2016; 36: 156–168.
43.
WeissmanMMWickramaratnePPilowskyDJ. The effects on children of depressed mothers’ remission and relapse over 9 months. Psychol Med. 2014; 44: 2811–2824.
44.
BrownASGyllenbergDMalmH. Association of selective serotonin reuptake inhibitor exposure during pregnancy with speech, scholastic, and motor disorders in offspring. JAMA Psychiatry. 2016; 73: 1163–1170.
45.
CohenLSNonacsR.Neurodevelopmental implications of fetal exposure to selective serotonin reuptake inhibitors and untreated maternal depression: weighing relative risks. JAMA Psychiatry. 2016; 73: 1170–1172.
46.
LupattelliAWoodMYstromE. Effect of time-dependent selective serotonin reuptake inhibitor antidepressants during pregnancy on behavioral, emotional, and social development in preschool-aged children. J Am Acad Child Adolesc Psychiatry. 2018; 57: 200–208.
47.
HanleyGEBrainUOberlanderTF. Prenatal exposure to serotonin reuptake inhibitor anti-depressants and childhood behavior. Pediatr Res. 2015; 78: 174–180.
48.
BiedermanJWozniakJKielyK. CBCL clinical scales discriminate prepubertal children with structured interview-derived diagnosis of mania from those with ADHD. J Am Acad Child Adolesc Psychiatry. 1995; 34: 464–471.
49.
BiedermanJPettyCRMonuteauxMC. The Child Behavior Checklist-Pediatric Bipolar Disorder profile predicts a subsequent diagnosis of bipolar disorder and associated impairments in ADHD youth growing up: a longitudinal analysis. J Clin Psychiatry. 2009; 70: 732–740.
50.
BiedermanJPettyCRDayH. Severity of the aggression/anxiety-depression/attention child behavior checklist profile discriminates between different levels of deficits in emotional regulation in youth with attention-deficit hyper-activity disorder. J Dev Behav Pediatr. 2012; 33: 236–243.
51.
BiedermanJFaraoneS VDoyleA. Convergence of the Child Behavior Checklist with structured interview-based psychiatric diagnoses of ADHD children with and without comorbidity. J Child Psychol Psychiatry. 1993; 34: 1241–1251.
52.
YangFChenJMiaoMH. Risk of autism spectrum disorder in offspring following paternal use of selective serotonin reuptake inhibitors before conception: a population-based cohort study. BMJ Open. 2017; 7: e016368.
